Navigation Links
Founder and CEO of HealthTech, Molly Coye, MD, Assumes Leadership of CalRHIO
Date:7/1/2009

s helped the nation's most influential hospitals, health care systems and government agencies prioritize and invest in technologies that make health care safer and more affordable," said Coye. "It has become increasingly clear that our industry-leading research must become more widely accessible as the nation seeks to transform health care and leverage emerging clinical and health information technologies to do so. Our vision has always been to advance the use of new technologies to improve the health of people and communities. Affiliating with PHI is the best way to assure fulfillment of our vision."

HealthTech and PHI are currently exploring the best way to archive and disseminate HealthTech's work in order to make it widely available to researchers, public health leaders, policy leaders and health providers both in the U.S. and globally.

"HealthTech's impressive body of work complements our mission to advance community health and improve the efficacy of public health statewide, nationally and internationally," said Mary A. Pittman, DrPH, president and CEO of PHI. "We are thrilled to be in a position to extend the influence of HealthTech's important work and to leverage its assets to ensure that public health is included in the dialog on health reform."

Coye has extensive experience in both the public and private sectors. She served as Commissioner of Health for the State of New Jersey and Director of the California Department of Health Services, in addition to heading the Division of Public Health at the Johns Hopkins School of Hygiene and Public Health, leading marketing and product development for interactive health communication and disease management at HealthDesk Corp, serving as Executive Vice President for the Good Samaritan Health System, and directing The Lewin Group's West Coast office.

As a member of the Institute of Medicine, Coye co-authored the reports To Err is Human and
'/>"/>

SOURCE CalRHIO
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Angelo Masciantonio, CEO and Co-Founder of HTH Worldwide Named Ernst & Young 2009 Entrepreneur Of The Year(R) in Greater Philadelphia
2. Chopra Center Co-Founder and Best-Selling Author David Simon, M.D., Will Lead Two Special Events in New York City This June
3. Medeguide Founder to Lead Online Healthcare Marketing Workshop at the Healthcare Travel Conference in Singapore
4. Founder of Snoring Isn't Sexy, LLC Addresses Annual Meeting of the American Academy of Dental Sleep Medicine
5. Helping Dad Stay Independent: The Best Fathers Day Gift for an Aging Parent - A Checklist from Dr. Dan Tobin, Founder and CEO of Care Support of America
6. GECKO Founder to Race 135 Miles Across Death Valley in the Badwater Ultramarathon to Raise Funds and Awareness for New Nonprofit Dedicated to Helping Kids Get Outdoors
7. Principle Pharmacy Group, Inc. Announces Founders Retirement, New CEO, Officers and Appointments to Its Board of Directors
8. Network Merchants, Inc (NMI) Founders Donate $50,000 to Schaumburgs Childrens Home & Aid
9. Founder of Snoring Isn't Sexy, LLC Urges All Dentists to Screen Their Patients for Snoring and Obstructive Sleep Apnea
10. Kay Renz PR to Workout Publicity Routine for Adriana Martin, Founder of Fit Mom For Life
11. Plane Crash Claims Arcadians Chairman and Founder, John H. Austin M.D.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... (PRWEB) February 28, 2015 The MCA ... across Malaysia into one platform and gears towards the ... , A series of group talks in smaller groups ... Nation Building, Education, Personal Development, Leadership, Entrepreneurship, Healthcare, Social ... raise awareness of Malaysian youths. , Young ...
(Date:2/28/2015)... 2015 With their commitment to achieving ... an additional exercise to their already robust library of ... most commonly known as, is often performed on a ... executed in a relatively safe manner and can be ... The full description of “Rope Pulls” is located in ...
(Date:2/28/2015)... BC (PRWEB) February 28, 2015 Vancouver personal ... personal injury claims are affected by time limits. They stated ... weaken a person’s claim or even nullify it. Many a ... effects on a client’s rights under BC law. As a ... are affected by accidents should consult a personal injury lawyer ...
(Date:2/28/2015)... Pioneer Millworks reclaimed USA wood will ... Construction Materials Show, an annual, premier sustainable building event ... and top manufacturers of the latest building products, services ... sourced and manufactured by Pioneer Millworks from their Oregon ... at restaurants, hotels, retailers, and corporate offices. Nichibi ...
(Date:2/28/2015)... Kaylie Corrigan, Outdoor Supervisor at ... and current student obtaining her Masters degree in social ... forum in psychoeducation on substance use for teens at ... part of her studies. , “Even though these students ... counseling at the high school and junior high school ...
Breaking Medicine News(10 mins):Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2
... a stroke could run a further risk of further strokes ... a new study. Recurrent// strokes could also disable nearly 50% ... the University at Chicago said” Stroke incidence and mortality are ... of this risk may be explained by a greater vascular ...
... cases of E. coli have been confirmed in Wisconsin, ... been caused by bagged spinach. One person has ... ,Governor Doyle said that 15 of the 30 ... are battling severe infection. Majority of the patients are ...
... chronic disease – myositis -- will speak to congressional staff ... the staff// hearing them on this day – designated 'Myositis ... this little-known and poorly understood disease. Internationally-known male model and ... personal friend, who is prominent in Europe and has the ...
... ever-rising obesity rates all over the world sparking many lifestyle ... just be what the doctor ordered. A pill// is soon ... risk. A mere consumption of the pill once or twice ... better glucose management, thus offsetting diabetes. ,The ...
... study at the Mayo Clinic has found that injecting an ... ,Men with abnormal digital rectal exams or elevated ... usually get prostate biopsies done. ,Nearly 16% pf the patients ... biopsy, according to a new study presented at the annual ...
... 42nd Annual Meeting of the European Association for the ... HCl), an oral// antidiabetic medication, demonstrated significant cardiovascular benefits ... C and acute coronary syndrome in patients with type ... leading cause of premature death in patients with diabetes. ...
Cached Medicine News:Health News:ACTOS Linked to Several Cardiovascular Benefits 2Health News:ACTOS Linked to Several Cardiovascular Benefits 3Health News:ACTOS Linked to Several Cardiovascular Benefits 4
(Date:2/27/2015)... ON , Feb. 27, 2015 /CNW/ - Covalon Technologies ... medical technologies company, today announced financial results for its ... For the three months ended December 31, 2014, revenue ... the quarter was $229,820 or $0.02 per share.  ... , said "I am very pleased with the significant ...
(Date:2/27/2015)... 27, 2015  Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology, announced today that ... Officer, will present live at VirtualInvestorConferences.com on March ... join us for this Company update," said Mr. ... commercial launch of the exVive3D Liver, Bioprinted Human ...
(Date:2/27/2015)... 2015  Uroplasty, Inc. (NASDAQ: UPI ), a ... proprietary products to treat voiding dysfunctions, today announced that ... on Tuesday, March 10, 2015. Rob Kill , ... Financial Officer, will present at 4:00 p.m. Pacific Time ... conference at the Ritz Carlton in Laguna ...
Breaking Medicine Technology:Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4Uroplasty to Participate in the 27th Annual ROTH Conference 2
... KENILWORTH, N.J., Dec. 17 Schering-Plough,Corporation (NYSE: ... that,demonstrated that Asenapine, a fast-dissolving, sublingual tablet being,developed ... placebo,and well tolerated in treating patients with acute ... mg twice daily and 10 mg twice,daily were ...
... Company Initiates Phase1b/2 Clinical Trial in Breast ... PLAINFIELD, N.J., Dec. 17 PTC,Therapeutics, Inc. ... development, and commercialization of small-molecule drugs,targeting post-transcriptional ... Phase 1 data regarding PTC299, its novel,internally ...
Cached Medicine Technology:New Study Results Show Asenapine More Effective Than Placebo in the Treatment of Acute Schizophrenia 2New Study Results Show Asenapine More Effective Than Placebo in the Treatment of Acute Schizophrenia 3New Study Results Show Asenapine More Effective Than Placebo in the Treatment of Acute Schizophrenia 4PTC Therapeutics Presents Encouraging Phase 1 Results of its Novel VEGF Inhibitor, PTC299, at 30th Annual San Antonio Breast Cancer Symposium 2PTC Therapeutics Presents Encouraging Phase 1 Results of its Novel VEGF Inhibitor, PTC299, at 30th Annual San Antonio Breast Cancer Symposium 3PTC Therapeutics Presents Encouraging Phase 1 Results of its Novel VEGF Inhibitor, PTC299, at 30th Annual San Antonio Breast Cancer Symposium 4
... easy to configure for gravimetric calibration and ... standard method or enter your own parameters ... QualiTrace automatically manages the calibration protocol with ... balance to the software, which establishes the ...
Reservoir, High Profile, Multi Well, 8 Row, Pyramid Bottom, 32mL Available Sterile...
Reservoir, High Profile, Single Well, 384ch-format, Pyramid Bottom, 282mL Available Sterile...
Reservoir, High Profile, Single Well, 12 Row, Pyramid Bottom Available Sterile...
Medicine Products: